Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region-Reference-Cited by-同舟云学术

Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region

Published:2015-12-29 Issue:5 Volume:29 Page:673-681
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Rivera Rodolfo F.^ORCID,Guido Davide,Del Vecchio Lucia,Corghi Enzo,D’Amico Marco,Camerini Corrado,Spotti Donatella,Galassi Andrea,Pozzi Claudio,Cancarini Giovanni,Pontoriero Giuseppe,Locatelli Francesco

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-015-0254-5.pdf

Reference33 articles.

1. Sunder-Plassmann G, Hörl WH (1995) Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 10(11):2070–2076

2. Fishbane S, Frei GL, Maesaka J (1995) Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26(1):41–46

3. Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC et al (2010) Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant 25(9):2846–2850

4. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease (2012) Chapter 2: Use of iron to treat anemia in CKD. Kidney Int Suppl 2(4):292–8

5. Pfeffer MA, Burdmann EA, Chen C-Y, Cooper ME, de Zeeuw D, Eckardt K-U et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361(21):2019–32

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reacciones de hipersensibilidad en hemodiálisis secundarias a membranas sintéticas;Medicina Clínica;2023-02

2. Hypersensitivity reactions in hemodialysis secondary to synthetic membranes;Medicina Clínica (English Edition);2023-02

3. Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study;Journal of Clinical Medicine;2021-03-23

4. Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center;Therapeutic Apheresis and Dialysis;2020-03-20

5. La sindrome anemica cardio-renale. Terza parte: Terapia;Giornale di Tecniche Nefrologiche e Dialitiche;2018-06